Ventas, Inc. (NYSE:VTR - Get Free Report) passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $87.25 and traded as low as $86.78. Ventas shares last traded at $86.8320, with a volume of 2,646,503 shares.
Wall Street Analysts Forecast Growth
VTR has been the subject of a number of research reports. Citigroup increased their target price on shares of Ventas from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, August 4th. Wells Fargo & Company raised their target price on Ventas from $96.00 to $102.00 and gave the stock an "overweight" rating in a research note on Monday. Barclays reduced their target price on Ventas from $102.00 to $91.00 and set an "equal weight" rating for the company in a report on Tuesday, October 13th. The Goldman Sachs Group upped their price target on Ventas from $110.00 to $114.00 and gave the company a "buy" rating in a research report on Friday, July 24th. Finally, Mizuho lowered their price target on shares of Ventas from $104.00 to $101.00 and set an "outperform" rating on the stock in a report on Monday. Seventeen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $99.82.
Read Our Latest Research Report on Ventas
Ventas Stock Performance
The firm has a market cap of $45.92 billion, a PE ratio of 163.84, a price-to-earnings-growth ratio of 3.61 and a beta of 0.77. The company has a 50 day simple moving average of $86.23 and a 200-day simple moving average of $87.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.43 and a quick ratio of 0.43.
Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings data on Tuesday, October 27th. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.98 by ($0.85). Ventas had a return on equity of 1.86% and a net margin of 3.86%. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the firm posted $0.88 earnings per share. The company's revenue was up 23.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Ventas, Inc. will post 3.89 EPS for the current year.
Ventas Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Wednesday, September 30th. Ventas's payout ratio is 392.45%.
Institutional Investors Weigh In On Ventas
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Ventas during the 2nd quarter valued at about $4,953,439,000. Legal & General Group Plc purchased a new position in Ventas in the second quarter worth about $501,850,000. Deutsche Bank AG bought a new position in shares of Ventas in the second quarter worth approximately $451,822,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Ventas by 5.5% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,981,404 shares of the real estate investment trust's stock worth $442,349,000 after buying an additional 258,859 shares in the last quarter. Finally, Bank of America Corp DE bought a new position in shares of Ventas in the second quarter worth approximately $390,395,000. 94.18% of the stock is currently owned by institutional investors.
About Ventas
(
Get Free Report)
Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.